Table 2 |
||||||
|
Treatments used by patients in the study, and the Pearson correlation with age, age at diagnosis and years since diagnosis with usage (scored 3 = 'At present', 2 = 'In the past' and 1 = 'Never used'). |
||||||
|
Usage |
Correlation of usage with: |
|||||
|
|
|
|||||
|
"Never used" |
"In the past" |
"At present" |
Age |
Age at diagnosis |
Years since diagnosis |
|
|
|
|
|||||
|
Regular antibiotics |
10 (11%) |
36 (39%) |
46 (50%) |
.042 (NS) |
.227 (NS) |
.236 (NS) |
|
Bronchodilators (inhaler or tablets) |
15 (17%) |
23 (25%) |
53 (58%) |
.166 (NS) |
.122 (NS) |
.008 (NS) |
|
Mucolytics to thin the sputum |
75 (89%) |
6 (7%) |
3 (4%) |
.029 (NS) |
.092 (NS) |
-.046 (NS) |
|
Physiotherapy |
1 (1%) |
21 (23%) |
69 (76%) |
-.139 (NS) |
-.022 (NS) |
-.174 (NS) |
|
Breathing exercises and techniques |
11(12%) |
13 (14%) |
68 (74%) |
.119 (NS) |
.228 (NS) |
-.120 (NS) |
|
Expectorants |
64 (73%) |
19 (22%) |
5 (6%) |
.409 (p < .001) |
.420 (p = .001) |
.176 (NS) |
|
Antacids or other drugs for heartburn or reflux |
64 (72%) |
16 (18%) |
9 (10%) |
.380 (p < .001) |
.398 (p = .002) |
.101 (NS) |
|
|
||||||
|
McManus et al. BMC Pulmonary Medicine 2003 3:4 doi:10.1186/1471-2466-3-4 |
||||||